Cutler Group’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-1,508
Closed -$1K – 6843
2016
Q4
$1K Hold
1,508
– – ﹤0.01% 6042
2016
Q3
$4K Buy
1,508
+1,333
+762% +$60.5K ﹤0.01% 5154
2016
Q2
$8K Sell
175
-408
-70% -$32.2K ﹤0.01% 4431
2016
Q1
$12K Sell
583
-234
-29% -$18.5K ﹤0.01% 3853
2015
Q4
$47K Buy
+817
New +$131K ﹤0.01% 2528

Other funds holding LRMR

Cutler Group's LRMR Position: Q1 2024 in Review

Cutler Group sold out of Larimar Therapeutics (LRMR) in Q1 2024, closing a stake of 400 shares — an estimated $3.12K sold.

Cutler Group first reported a position in LRMR in Q4 2015 and held it in 22 quarters. The position peaked at $34K in Q4 2015. 104 funds tracked by Wall St. Rank hold LRMR as of Q1 2024.

  • Cutler Group reported no remaining Larimar Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 400 Larimar Therapeutics shares in Q1 2024, an estimated $3.12K.
  • Cutler Group first reported a position in Larimar Therapeutics in Q4 2015 and held it in 22 quarters.
  • Cutler Group's Larimar Therapeutics position peaked at $34K in Q4 2015.
  • 104 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.